OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹281.2 Cr | 2.9% | -5% | 88.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,224.0 Cr | 3.4% | 2.2% | 13.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,046.0 Cr | 5.3% | 3.9% | 51.8% | Stock Analytics | |
CIPLA | ₹123,416.0 Cr | 3.3% | 1.2% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,834.0 Cr | 4% | 6.3% | 29.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,036.0 Cr | 6.1% | 2.3% | -3.2% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 2.9% |
-5% |
88.5% |
SENSEX | 5.9% |
7.3% |
8.4% |
You may also like the below Video Courses